Cargando…

Tumor Lymphatic Interactions Induce CXCR2-CXCL5 Axis and Alter Cellular Metabolism and Lymphangiogenic Pathways to Promote Cholangiocarcinoma

Cholangiocarcinoma (CCA), or cancer of bile duct epithelial cells, is a very aggressive malignancy characterized by early lymphangiogenesis in the tumor microenvironment (TME) and lymph node (LN) metastasis which correlate with adverse patient outcome. However, the specific roles of lymphatic endoth...

Descripción completa

Detalles Bibliográficos
Autores principales:	Roy, Sukanya, Kumaravel, Subhashree, Banerjee, Priyanka, White, Tori K., O’Brien, April, Seelig, Catherine, Chauhan, Rahul, Ekser, Burcin, Bayless, Kayla J., Alpini, Gianfranco, Glaser, Shannon S., Chakraborty, Sanjukta
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8623887/ https://www.ncbi.nlm.nih.gov/pubmed/34831316 http://dx.doi.org/10.3390/cells10113093

Ejemplares similares

Inflammation and Progression of Cholangiocarcinoma: Role of Angiogenic and Lymphangiogenic Mechanisms
por: Roy, Sukanya, et al.
Publicado: (2019)

Conjugated Bile Acids Promote Lymphangiogenesis by Modulation of the Reactive Oxygen Species–p90RSK–Vascular Endothelial Growth Factor Receptor 3 Pathway
por: Banerjee, Priyanka, et al.
Publicado: (2023)

Current Advances in Basic and Translational Research of Cholangiocarcinoma
por: Sato, Keisaku, et al.
Publicado: (2021)

Molecular Mechanisms Linking Risk Factors to Cholangiocarcinoma Development
por: Ceci, Ludovica, et al.
Publicado: (2022)

Neuroendocrine Changes in Cholangiocarcinoma Growth
por: Sato, Keisaku, et al.
Publicado: (2020)

Cyclic AMP Signaling in Biliary Proliferation: A Possible Target for Cholangiocarcinoma Treatment?
por: Baiocchi, Leonardo, et al.
Publicado: (2021)

Mesenchymal stem cells promote lymphangiogenic properties of lymphatic endothelial cells
por: Robering, Jan W., et al.
Publicado: (2018)

FGF1 Signaling Modulates Biliary Injury and Liver Fibrosis in the Mdr2(−/−) Mouse Model of Primary Sclerosing Cholangitis
por: O’Brien, April, et al.
Publicado: (2022)

TIE-2-expressing monocytes are lymphangiogenic and associate specifically with lymphatics of human breast cancer
por: Bron, Sylvian, et al.
Publicado: (2015)

Kallistatin exerts anti-lymphangiogenic effects by inhibiting lymphatic endothelial cell proliferation, migration and tube formation
por: Ma, Caiqi, et al.
Publicado: (2017)

CXCL7-Mediated Stimulation of Lymphangiogenic Factors VEGF-C, VEGF-D in Human Breast Cancer Cells
por: Yu, Minghuan, et al.
Publicado: (2010)

Feedback Signaling between Cholangiopathies, Ductular Reaction, and Non-Alcoholic Fatty Liver Disease
por: Zhou, Tianhao, et al.
Publicado: (2021)

CXCR4/ACKR3/CXCL12 axis in the lymphatic metastasis of vulvar squamous cell carcinoma
por: Rusetska, Natalia, et al.
Publicado: (2022)

KSHV Induction of Angiogenic and Lymphangiogenic Phenotypes
por: DiMaio, Terri A., et al.
Publicado: (2012)

Metabolomics revealed the influence of breast cancer on lymphatic endothelial cell metabolism, metabolic crosstalk, and lymphangiogenic signaling in co-culture
por: Acevedo-Acevedo, Suehelay, et al.
Publicado: (2020)

Identification of Gene Expression Differences between Lymphangiogenic and Non-Lymphangiogenic Non-Small Cell Lung Cancer Cell Lines
por: Regan, Erin, et al.
Publicado: (2016)

Emerging Therapeutic Strategies in The Fight Against Primary Biliary Cholangitis
por: Medford, Abigail, et al.
Publicado: (2023)

Lymphangiogenic factors are associated with the severity of hypersensitivity pneumonitis
por: Yamashita, Masahiro, et al.
Publicado: (2015)

Knockout of secretin ameliorates biliary and liver phenotypes during alcohol-induced hepatotoxicity
por: Kyritsi, Konstantina, et al.
Publicado: (2023)

CXCR7 Functions as a Scavenger for CXCL12 and CXCL11
por: Naumann, Ulrike, et al.
Publicado: (2010)

Expression of the CXCL12/CXCR4 and CXCL16/CXCR6 axes in cervical intraepithelial neoplasia and cervical cancer
por: Huang, Yu, et al.
Publicado: (2013)

Dysregulation of Iron Metabolism in Cholangiocarcinoma Stem-like Cells
por: Raggi, Chiara, et al.
Publicado: (2017)

On-Chip Organoid Formation to Study CXCR4/CXCL-12 Chemokine Microenvironment Responses for Renal Cancer Drug Testing
por: Ozcelik, Adem, et al.
Publicado: (2022)

Blockade of CXCL12/CXCR4 signaling inhibits intrahepatic cholangiocarcinoma progression and metastasis via inactivation of canonical Wnt pathway
por: Zhao, Shengqiang, et al.
Publicado: (2014)

Role of Non-Coding RNAs in the Progression of Liver Cancer: Evidence from Experimental Models
por: O’Brien, April, et al.
Publicado: (2019)

CXCL12/SDF-1 and CXCR4
por: Nagasawa, Takashi
Publicado: (2015)

Mast cells selectively target large cholangiocytes during biliary injury via H2HR‐mediated cAMP/pERK1/2 signaling
por: Zhou, Tianhao, et al.
Publicado: (2022)

Endothelin Receptor-A Inhibition Decreases Ductular Reaction, Liver Fibrosis, and Angiogenesis in a Model of Cholangitis
por: Owen, Travis, et al.
Publicado: (2023)

Expression and function of CXCL12/CXCR4/CXCR7 in thyroid cancer
por: ZHU, XIAOLI, et al.
Publicado: (2016)

CXCR4/CXCR7/CXCL12-Axis in Follicular Thyroid Carcinoma
por: Werner, Thomas Artur, et al.
Publicado: (2018)

The Role of the CXCL12/CXCR4/CXCR7 Chemokine Axis in Cancer
por: Shi, Yi, et al.
Publicado: (2020)

Chemokine axes CXCL12/CXCR4 and CXCL16/CXCR6 correlate with lymph node metastasis in epithelial ovarian carcinoma
por: Guo, Li, et al.
Publicado: (2011)

Lymphangiogenic Gene Therapy With Minimal Blood Vascular Side Effects
por: Saaristo, Anne, et al.
Publicado: (2002)

Lymphangiogenic therapy prevents cardiac dysfunction by ameliorating inflammation and hypertension
por: Song, LouJin, et al.
Publicado: (2020)

Involvement of CXCR4/CXCR7/CXCL12 Interactions in Inflammatory Bowel Disease
por: Werner, Lael, et al.
Publicado: (2013)

Colorectal Cancer: The Contribution of CXCL12 and Its Receptors CXCR4 and CXCR7
por: Goïta, Aïssata Aimée, et al.
Publicado: (2022)

The CXCL8-CXCR1/2 pathways in cancer
por: Liu, Qian, et al.
Publicado: (2016)

The role of CXCR3 and its ligands CXCL10 and CXCL11 in the pathogenesis of celiac disease
por: Haghbin, Mahrokh, et al.
Publicado: (2019)

Epithelial chemokine CXCL14 synergizes with CXCL12 via allosteric modulation of CXCR4
por: Collins, Paul J., et al.
Publicado: (2017)

Involvement of the CXCR7/CXCR4/CXCL12 Axis in the Malignant Progression of Human Neuroblastoma
por: Liberman, Julie, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_1bo7r4oc1stfs1nv62rep06v0m